3 unknown, 2 completed, 2 recruiting, 1 terminated. 3 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hypoactive Delirium: new trials by email Literature Review of Hypoactive Delirium trials Research Report on Hypoactive Delirium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rivastigmine as an Antidote for Clozapine-induced Central Nervous System Depression and Delirium Rivastigmine - Anticholinergic Delirium, Clozapine Poisoning | Phase 4 | Completed | Alexandria University | 100 | 2025-12-08 | 2026-09-21 |
| A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium Healthcare Provider, Caregiver Perception - Hypoactive Delirium | Recruiting | M.D. Anderson Cancer Center | 100 | 2024-03-25 | 2026-03-04 | |
| An Observational Study of Emergence and Hypoactive Delirium After Anesthesia noninvasive blood pressure, 3 lead ECG, peripheral oxygen saturation - Emergence Delirium, Hypoactive Delirium | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 150 | 2022-12-01 | 2022-10-17 | |
| The Basel BOMP-AID Randomized Trial Melatonin (Circadin ®), Placebo - Hypoactive Delirium | Phase 4 | Recruiting | University Hospital, Basel, Switzerland | 190 | 2022-01-03 | 2026-06-11 |
| Delirium Prevention in Patients From the Intensive Care Unit (DELA) Delirium prevention program - Hypoactive Delirium, Hyperactive Delirium | Not applicable | Unknown | Universidad de Santander | 200 | 2017-10-01 | 2017-10-27 |
| Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure Flumazenil, Placebo - Hypoactive Delirium | Phase 4 | Terminated | University of California, Davis | 22 | 2016-03-01 | 2020-07-23 |
| Treatment of Hypoactive Delirium and Outcome Measures Haloperidol, Placebo, non-pharmacologic measures - Hypoactive Delirium | Phase 3 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 60 | 2016-01-01 | 2017-04-21 |
| A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD) Hyperactive Delirium, Hypoactive Delirium | Completed | Stanford University | 300 | 2014-02-01 | 2019-05-17 |
Delirium (3) · Emergence Delirium (1) · Pain (1)
Confusion (4) · Mental Disorders (4) · Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurocognitive Disorders (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Delirium (1) · Pathologic Processes (1) · Postoperative Complications (1)
Flumazenil (1) · Haloperidol (1) · Health Personnel (1) · Melatonin (1) · Rivastigmine (1) · Tablets (1)
Alexandria University (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · M.D. Anderson Cancer Center (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Stanford University (1) · Universidad de Santander (1) · University Hospital, Basel, Switzerland (1) · University of California, Davis (1)
United States (3) · Canada (1) · Colombia (1) · Egypt (1) · Mexico (1) · Switzerland (1)
Alexa Hollinger, MD (1) · Claudia C Torres, RN, MSc (1) · Erwin Chiquete, MD, PhD (1) · Jeremiah J Duby, PharmD, BCPS (1) · Jose R Maldonado, M.D. (1) · Kendra J Schomer, PharmD (1) · Michael Tang, MD (1) · Naima A Sherif, Professor of Forensic Medicine (1) · Ragaa T Darwish, Professor of Forensic Medicine (1) · Sahar Y Issa, Assoc Prof Forensic Med (1)